News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytomX Therapeutics, Inc. Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors



3/6/2012 6:26:36 AM

SAN FRANCISCO--(BUSINESS WIRE)--CytomX Therapeutics, Inc., a leader in the field of highly targeted monoclonal antibody therapies, today announced the appointment of Hoyoung Huh, M.D., Ph.D., as chairman of the Board of Directors. Former chairman Charles Homcy, M.D., venture partner at Third Rock Ventures, will continue to serve on the Board of Directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES